218 related articles for article (PubMed ID: 16675545)
41. Decreased expression of apelin in placentas from severe pre-eclampsia patients.
Inuzuka H; Nishizawa H; Inagaki A; Suzuki M; Ota S; Miyamura H; Miyazaki J; Sekiya T; Kurahashi H; Udagawa Y
Hypertens Pregnancy; 2013 Nov; 32(4):410-21. PubMed ID: 23844873
[TBL] [Abstract][Full Text] [Related]
42. The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term.
Bates DO; MacMillan PP; Manjaly JG; Qiu Y; Hudson SJ; Bevan HS; Hunter AJ; Soothill PW; Read M; Donaldson LF; Harper SJ
Clin Sci (Lond); 2006 May; 110(5):575-85. PubMed ID: 16451124
[TBL] [Abstract][Full Text] [Related]
43. The regional expression of insulin-like growth factor II (IGF-II) and insulin-like growth factor binding protein-1 (IGFBP-1) in the placentae of women with pre-eclampsia.
Gratton RJ; Asano H; Han VK
Placenta; 2002 Apr; 23(4):303-10. PubMed ID: 11969341
[TBL] [Abstract][Full Text] [Related]
44. Premenstrual regulation of the pro-angiogenic factor CYR61 in human endometrium.
Gashaw I; Stiller S; Böing C; Kimmig R; Winterhager E
Endocrinology; 2008 May; 149(5):2261-9. PubMed ID: 18202125
[TBL] [Abstract][Full Text] [Related]
45. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer.
Holloway SE; Beck AW; Girard L; Jaber MR; Barnett CC; Brekken RA; Fleming JB
J Am Coll Surg; 2005 Mar; 200(3):371-7. PubMed ID: 15737847
[TBL] [Abstract][Full Text] [Related]
46. [Expression of various subtypes of human leukocyte antigen-G in placenta of patients complicated with severe pre-eclampsia].
He YD; Li YL; Chen Q
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):29-32. PubMed ID: 22455690
[TBL] [Abstract][Full Text] [Related]
47. Dual specificity phosphatase 9 (DUSP9) expression is down-regulated in the severe pre-eclamptic placenta.
Czikk MJ; Drewlo S; Baczyk D; Adamson SL; Kingdom J
Placenta; 2013 Feb; 34(2):174-81. PubMed ID: 23276385
[TBL] [Abstract][Full Text] [Related]
48. Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells.
Chen N; Leu SJ; Todorovic V; Lam SC; Lau LF
J Biol Chem; 2004 Oct; 279(42):44166-76. PubMed ID: 15308622
[TBL] [Abstract][Full Text] [Related]
49. Expression and regulation of CCN genes in murine osteoblasts.
Parisi MS; Gazzerro E; Rydziel S; Canalis E
Bone; 2006 May; 38(5):671-7. PubMed ID: 16311085
[TBL] [Abstract][Full Text] [Related]
50. Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma.
Walker TM; Van Ginkel PR; Gee RL; Ahmadi H; Subramanian L; Ksander BR; Meisner LF; Albert DM; Polans AS
Arch Ophthalmol; 2002 Dec; 120(12):1719-25. PubMed ID: 12470148
[TBL] [Abstract][Full Text] [Related]
51. Expression of insulin-like growth factor-II and insulin-like growth factor binding protein-1 in the placental basal plate from pre-eclamptic pregnancies.
Shin JC; Lee JH; Yang DE; Moon HB; Rha JG; Kim SP
Int J Gynaecol Obstet; 2003 Jun; 81(3):273-80. PubMed ID: 12767569
[TBL] [Abstract][Full Text] [Related]
52. The CCN3 gene coding for an extracellular adhesion-related protein is transcriptionally activated by the p53 tumor suppressor.
Böhlig L; Metzger R; Rother K; Till H; Engeland K
Cell Cycle; 2008 May; 7(9):1254-61. PubMed ID: 18418052
[TBL] [Abstract][Full Text] [Related]
53. Abnormal expression of the costimulatory molecule B7-H4 in placental chorionic villous and decidual basalis tissues of patients with preeclampsia and HELLP syndrome.
Duan L; Reisch B; Iannaccone A; Hadrovic E; Wu Y; Vogtmann R; Winterhager E; Kimmig R; Köninger A; Mach P; Gellhaus A
Am J Reprod Immunol; 2021 Sep; 86(3):e13430. PubMed ID: 33864713
[TBL] [Abstract][Full Text] [Related]
54. Adriana and Luisa Castellucci Award lecture 2001. Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies--a review.
Caniggia I; Winter JL
Placenta; 2002 Apr; 23 Suppl A():S47-57. PubMed ID: 11978059
[TBL] [Abstract][Full Text] [Related]
55. The expression of ccn3(nov) gene in musculoskeletal tumors.
Manara MC; Perbal B; Benini S; Strammiello R; Cerisano V; Perdichizzi S; Serra M; Astolfi A; Bertoni F; Alami J; Yeger H; Picci P; Scotlandi K
Am J Pathol; 2002 Mar; 160(3):849-59. PubMed ID: 11891184
[TBL] [Abstract][Full Text] [Related]
56. Aberrant TGFβ Signaling Contributes to Altered Trophoblast Differentiation in Preeclampsia.
Xu J; Sivasubramaniyam T; Yinon Y; Tagliaferro A; Ray J; Nevo O; Post M; Caniggia I
Endocrinology; 2016 Feb; 157(2):883-99. PubMed ID: 26653761
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of CCN3 in osteosarcoma.
Perbal B; Zuntini M; Zambelli D; Serra M; Sciandra M; Cantiani L; Lucarelli E; Picci P; Scotlandi K
Clin Cancer Res; 2008 Feb; 14(3):701-9. PubMed ID: 18245529
[TBL] [Abstract][Full Text] [Related]
58. Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression.
Li J; Gao X; Ji K; Sanders AJ; Zhang Z; Jiang WG; Ji J; Ye L
Oncol Rep; 2016 Nov; 36(5):2517-2525. PubMed ID: 27633176
[TBL] [Abstract][Full Text] [Related]
59. Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia.
Holdsworth-Carson SJ; Lim R; Mitton A; Whitehead C; Rice GE; Permezel M; Lappas M
Placenta; 2010 Mar; 31(3):222-9. PubMed ID: 20045185
[TBL] [Abstract][Full Text] [Related]
60. MSX2 Induces Trophoblast Invasion in Human Placenta.
Liang H; Zhang Q; Lu J; Yang G; Tian N; Wang X; Tan Y; Tan D
PLoS One; 2016; 11(4):e0153656. PubMed ID: 27088357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
